Recent Finacing
Recent Raise
Coeptis Therapeutics develops allogeneic and engineered cell therapy platforms—DVX201 NK cells, SNAP‑CARs, GEAR cells—and companion diagnostics for cancer, autoimmune, and infectious diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Coeptis Therapeutics.
